Seamlessly Integrated

Strategy Consulting &
Transaction Advisory Services

For the Life Sciences Industry

More About Us Play the Back Bay Video

Drivers of High Valuation for Early-Stage Transcatheter Mitral Valve Technologies

Medical device companies developing next-generation mitral valve repair and replacement technologies have generated unprecedentedly high valuations at ever-earlier stages of device development. Most high-impact medical device deals occurred after the product has reached U.S. commercialization. Will transcatheter mitral valve technologies continue to fire up MedTech and drive aggressive early-stage acquisition and high valuation? What are the next steps for the device manufacturers and investors in the heart valve space? Back Bay’s cardiovascular and med device experts explore these questions in the latest white paper from the life science experts at Back Bay Life Science Advisors.

Early-Stage Transcatheter Mitral Valve Technologies White Paper Cover

Results Matter